CSL's Horizon 2 Approach to 'Significantly' Boost Margins, Earnings, Jarden Says

MT Newswires Live

Nov 07

CSL's (ASX:CSL) phasing in of the Horizon 2 approach is taking longer than anticipated and does not appear to build upon the yield advantages in Horizon 1, but will still boost margins, earnings, and the cash flow of the business "significantly," Jarden said in a note on Thursday.

The company hosted the second day of its Capital Markets Day, where it was disclosed that Horizon 2, a manufacturing method that will improve the amount of immunoglobulin yield from plasma, is "very close" to being approved, according to the investment and advisory firm.

Horizon 2 is expected to deliver nearly 23% in yield improvement on its own and will not add to the yield of the previous method, Horizon 1. Horizon 2 will gradually replace Horizon 1 once approved.

Jarden said management demonstrated confidence in its success through planning for new US manufacturing modules dedicated to Horizon 2 at a projected cost of $1.5 billion.

The firm maintained an overweight rating on CSL and kept its price target of AU$287.14 per share.

CSL shares rose 1% in afternoon trade on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2581902691"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2581902691\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2581902691?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 10:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581902691","market":"hk","top_or_hot":-1,"title":"CSL's Horizon 2 Approach to 'Significantly' Boost Margins, Earnings, Jarden Says","media":"MT Newswires Live","content":"<html><body><p> CSL's (ASX:CSL) phasing in of the Horizon 2 approach is taking longer than anticipated and does not appear to build upon the yield advantages in Horizon 1, but will still boost margins, earnings, and the cash flow of the business \"significantly,\" Jarden said in a note on Thursday.</p><p>The company hosted the second day of its Capital Markets Day, where it was disclosed that Horizon 2, a manufacturing method that will improve the amount of immunoglobulin yield from plasma, is \"very close\" to being approved, according to the investment and advisory firm.</p><p>Horizon 2 is expected to deliver nearly 23% in yield improvement on its own and will not add to the yield of the previous method, Horizon 1. Horizon 2 will gradually replace Horizon 1 once approved.</p><p>Jarden said management demonstrated confidence in its success through planning for new US manufacturing modules dedicated to Horizon 2 at a projected cost of $1.5 billion.</p><p>The firm maintained an overweight rating on CSL and kept its price target of AU$287.14 per share.</p><p>CSL shares rose 1% in afternoon trade on Friday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CSL's Horizon 2 Approach to 'Significantly' Boost Margins, Earnings, Jarden Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCSL's Horizon 2 Approach to 'Significantly' Boost Margins, Earnings, Jarden Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-07 10:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> CSL's (ASX:CSL) phasing in of the Horizon 2 approach is taking longer than anticipated and does not appear to build upon the yield advantages in Horizon 1, but will still boost margins, earnings, and the cash flow of the business \"significantly,\" Jarden said in a note on Thursday.</p><p>The company hosted the second day of its Capital Markets Day, where it was disclosed that Horizon 2, a manufacturing method that will improve the amount of immunoglobulin yield from plasma, is \"very close\" to being approved, according to the investment and advisory firm.</p><p>Horizon 2 is expected to deliver nearly 23% in yield improvement on its own and will not add to the yield of the previous method, Horizon 1. Horizon 2 will gradually replace Horizon 1 once approved.</p><p>Jarden said management demonstrated confidence in its success through planning for new US manufacturing modules dedicated to Horizon 2 at a projected cost of $1.5 billion.</p><p>The firm maintained an overweight rating on CSL and kept its price target of AU$287.14 per share.</p><p>CSL shares rose 1% in afternoon trade on Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSL.AU","symbol_name":"CSL LIMITED","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2581902691","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581902691","pubTimestamp":1762482878,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"CSL's  phasing in of the Horizon 2 approach is taking longer than anticipated and does not appear to build upon the yield advantages in Horizon 1, but will still boost margins, earnings, and the cash flow of the business \"significantly,\" Jarden said in a note on Thursday.The company hosted the second day of its Capital Markets Day, where it was disclosed that Horizon 2, a manufacturing method that will improve the amount of immunoglobulin yield from plasma, is \"very close\" to being approved, according to the investment and advisory firm.Horizon 2 is expected to deliver nearly 23% in yield improvement on its own and will not add to the yield of the previous method, Horizon 1. Horizon 2 will gradually replace Horizon 1 once approved.Jarden said management demonstrated confidence in its success through planning for new US manufacturing modules dedicated to Horizon 2 at a projected cost of $1.5 billion.The firm maintained an overweight rating on CSL and kept its price target of AU$287.14 p","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CSL.AU":"CSL LIMITED","CSL":"卡莱尔伙伴"},"translate_title":"贾登表示，CSL的Horizon 2方法将“显着”提高利润率和收益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL":1.5,"CSL.AU":1.5},"content_text":"CSL's (ASX:CSL) phasing in of the Horizon 2 approach is taking longer than anticipated and does not appear to build upon the yield advantages in Horizon 1, but will still boost margins, earnings, and the cash flow of the business \"significantly,\" Jarden said in a note on Thursday.The company hosted the second day of its Capital Markets Day, where it was disclosed that Horizon 2, a manufacturing method that will improve the amount of immunoglobulin yield from plasma, is \"very close\" to being approved, according to the investment and advisory firm.Horizon 2 is expected to deliver nearly 23% in yield improvement on its own and will not add to the yield of the previous method, Horizon 1. Horizon 2 will gradually replace Horizon 1 once approved.Jarden said management demonstrated confidence in its success through planning for new US manufacturing modules dedicated to Horizon 2 at a projected cost of $1.5 billion.The firm maintained an overweight rating on CSL and kept its price target of AU$287.14 per share.CSL shares rose 1% in afternoon trade on Friday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}